Free Trial

CytoMed Therapeutics (GDTC) Income Statement & Balance Sheet

$2.16
+0.15 (+7.46%)
(As of 05/31/2024 ET)

CytoMed Therapeutics Income Statement, Balance Sheet and Cash Flow Statement


This page (NASDAQ:GDTC) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners